Pfizer Receives AUA Health Science Award

01 May 2023 | Monday | News

The American Urological Association (AUA) today announced that Pfizer Oncology is the recipient of the 2023 Health Science Award for its outstanding support of the educational, scientific and research goals of the AUA and the Urology Care Foundation in urologic cancer.

"We are proud to recognize Pfizer Oncology as the recipient of the 2023 Health Science Award," said Edward M. Messing, MD, FACS, president of the AUA. "Pfizer Oncology has become an instrumental partner with the AUA to support urologists seeking healthcare information to inform patient care."

 

The Health Science Award is presented annually to a company for its outstanding help in promoting the educational, scientific and research goals of the AUA. The presentation of this honor was held in conjunction with the 2023 AUA Annual Meeting in Chicago, Ill., on Saturday, April 29, 2023.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close